Interstitial lung disease in patients with small cell lung cancer

By Miyazaki Kunihiko   Satoh Hiroaki   Kurishima Koichi   Nakamura Ryota   Ishikawa Hiroichi   Kagohashi Katsunori   Hizawa Nobuyuki  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 763-767

Humana Press, Inc

Access to resources Recommend Favorite

Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia

By                          

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 477-482

Spandidos Publications

Access to resources Recommend Favorite

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro   Chevalier Thierry  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature

By        

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2419-2421

Spandidos Publications

Access to resources Recommend Favorite